Hybridan

Our passion is raising growth capital for exciting, fast growth companies that want to take their business to the next level. We raise capital for companies both listed and unlisted in the most efficient manner possible and pride ourselves as being one of the few consistently profitable broking firms in the City. This has been achieved through a highly disciplined approach when seeking to create both corporate and institutional relationships.

Your Partner for Growth

Your Partner for Growth, Hybridan

Equity Bottom-Up

<ul>
<li>Post a reverse in May 2024 at 11p into Amur Minerals, this UK clinical stage implantable drug delivery Company is focused on the localised and sustained delivery of chemotherapy drugs.</li>
<li>Curative cancer treatments are urgently required and the ChemoSeed platform enables the sustained delivery of chemotherapy drugs exactly where they are needed, so treatments become less toxic to the patient, while also improving performance and costeffectiveness.</li>
<li>ChemoSeed, CRISM's lead product, can be implanted directly into the tumour, so therapeutic concentrations of chemotherapy drugs reach the deep-seated tumour tissue. </li>
</ul>


Post a reverse in May 2024 at 11p into Amur Minerals, this UK clinical stage implantable drug delivery Company is focused on the localised and sustained delivery of chemotherapy drugs.
Curative cancer treatments are urgently required and the ChemoSeed platform enables the sustained delivery of chemotherapy drugs exactly where they are needed, so treatments become less toxic to the patient, while also improving performance and costeffectiveness.
ChemoSeed, CRISM's lead product, can be implanted directly into the tumour, so therapeutic concentrations of chemotherapy drugs reach the deep-seated tumour tissue. 


金曜日のテイクアウト：2026年1月16日

Crism Therapeutics

金曜日のテイクアウト：2026年1月16日